BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17159106)

  • 1. Spectrum and prognosis of neurologic complications after hematopoietic transplantation.
    Denier C; Bourhis JH; Lacroix C; Koscielny S; Bosq J; Sigal R; Said G; Adams D
    Neurology; 2006 Dec; 67(11):1990-7. PubMed ID: 17159106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemopoietic progenitor cell transplantation: 20 years' experience at the Hematology School "Farreras-Valentí"/Clinical Hospital of Barcelona].
    Rozman C; Carreras E; Sierra J; Rovira M; Urbano-Ispizua A; Marín P; Bladé J; Cervantes F; López-Guillermo A; Nomdedeu B; Rozman M; Aguilar JL; Vives-Corrons JL; Mazzara R; Ordinas A; Ribera JM; Feliu E; Castillo R; Grañena A; Montserrat E
    Med Clin (Barc); 1997 May; 108(18):681-6. PubMed ID: 9324582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of neurologic complications on outcome after heart transplant.
    van de Beek D; Kremers W; Daly RC; Edwards BS; Clavell AL; McGregor CG; Wijdicks EF
    Arch Neurol; 2008 Feb; 65(2):226-31. PubMed ID: 18268192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance.
    Siegal D; Keller A; Xu W; Bhuta S; Kim DH; Kuruvilla J; Lipton JH; Messner H; Gupta V
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1369-79. PubMed ID: 17950923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and therapeutic implications of neurological complications following paediatric haematopoietic stem cell transplantation.
    Weber C; Schaper J; Tibussek D; Adams O; Mackenzie CR; Dilloo D; Meisel R; Göbel U; Laws HJ
    Bone Marrow Transplant; 2008 Feb; 41(3):253-9. PubMed ID: 17982498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identical outcome after autologous or allogeneic genoidentical hematopoietic stem-cell transplantation in first remission of acute myelocytic leukemia carrying inversion 16 or t(8;21): a retrospective study from the European Cooperative Group for Blood and Marrow Transplantation.
    Gorin NC; Labopin M; Frassoni F; Milpied N; Attal M; Blaise D; Meloni G; Iori AP; Michallet M; Willemze R; Deconninck E; Harousseau JL; Polge E; Rocha V
    J Clin Oncol; 2008 Jul; 26(19):3183-8. PubMed ID: 18506024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of involved field radiation therapy in the treatment of relapsed or refractory non-Hodgkin lymphoma with high-dose chemotherapy followed by hematopoietic progenitor cell transplant.
    Wendland MM; Smith DC; Boucher KM; Asch JD; Pulsipher MA; Thomson JW; Shrieve DC; Gaffney DK
    Am J Clin Oncol; 2007 Apr; 30(2):156-62. PubMed ID: 17414465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative survival of long-term hematopoietic cell transplant recipients approaches general population rates.
    Nivison-Smith I; Simpson JM; Dodds AJ; Ma DD; Szer J; Bradstock KF
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1323-30. PubMed ID: 19747641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic kidney disease after myeloablative allogeneic hematopoietic stem cell transplantation.
    Kersting S; Hené RJ; Koomans HA; Verdonck LF
    Biol Blood Marrow Transplant; 2007 Oct; 13(10):1169-75. PubMed ID: 17889353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive total lymphoid irradiation-based reconditioning regimens enable engraftment after graft rejection or graft failure in patients treated with allogeneic hematopoietic stem cell transplantation.
    Heinzelmann F; Lang PJ; Ottinger H; Faul C; Bethge W; Handgretinger R; Bamberg M; Belka C
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):523-8. PubMed ID: 17869449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of relapsed acute leukemia after allogeneic transplantation: a single center experience.
    Arellano ML; Langston A; Winton E; Flowers CR; Waller EK
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):116-23. PubMed ID: 17222760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurologic complications in children after hemaopoietic stem cell transplantation: a single-center experience.
    Zaucha-Prazmo A; Jasiński M; Drabko K; Choma M; Wójcik B; Kowalczyk JR
    Transplant Proc; 2007 Nov; 39(9):2905-7. PubMed ID: 18022013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurologic complications of hematopoietic cell transplantation.
    Saiz A; Graus F
    Semin Neurol; 2010 Jul; 30(3):287-95. PubMed ID: 20577935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
    Fuji S; Kim SW; Fukuda T; Mori S; Yamasaki S; Morita-Hoshi Y; Ohara-Waki F; Heike Y; Tobinai K; Tanosaki R; Takaue Y
    Biol Blood Marrow Transplant; 2008 May; 14(5):510-7. PubMed ID: 18410893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.